What does european hospital liability — year 7 mean?

This metric measures the financial outcomes associated with the European hospital liability insurance product line during the seventh year of the reporting cycle. It reflects the company's competitive positioning and underwriting discipline within the European healthcare insurance market. Monitoring this metric allows for the assessment of sustained profitability and risk management effectiveness in a specialized insurance vertical.

King Pharmaceuticals KG European Hospital Liability — Year 7

Other product segments

General Liability

8.3%—

Commercial Auto Liability

5.2%—

All other lines

1.2%—

International

0.8%—

Similar metrics at other companies

CNAMedical Professional Liability — Year 7

6.1%+0.4pp

GLREHealth — Year 7

0%—

AXSInsurance — Year 7

8.8%—

CNAGeneral Liability — Year 7

8.4%+1.3pp

HMNAutomobile Liability — Year Seven

0.5%0.0pp

AIGUK/Europe Casualty and Financial lines — Year 7 (as a percent)

5.7%-0.1pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearSeven.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's european hospital liability — year 7.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's european hospital liability — year 7?: King Pharmaceuticals (KG) reported european hospital liability — year 7 of 7% in Q4 2025.
What does european hospital liability — year 7 mean?: This metric measures the financial outcomes associated with the European hospital liability insurance product line during the seventh year of the reporting cycle. It reflects the company's competitive positioning and underwriting discipline within the European healthcare insurance market. Monitoring this metric allows for the assessment of sustained profitability and risk management effectiveness in a specialized insurance vertical.